Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
about
Prostacyclin suppresses twist expression in the presence of indomethacin in bone marrow-derived mesenchymal stromal cells.Comparison of hIGF-1 gene transfection to the hBMSCs and human meniscal fibrochondrocytes.Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis.Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.VEGF Gene Polymorphisms are Associated with Risk of Tetralogy of Fallot.Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure.MicroRNA-208b Alleviates Post-Infarction Myocardial Fibrosis in a Rat Model by Inhibiting GATA4.Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy.Treatment of Myocardial Infarction with Gene-modified Mesenchymal Stem Cells in a Small Molecular Hydrogel.Bone Marrow and Adipose-Derived Mesenchymal Stem Cells Alleviate Methotrexate-Induced Pulmonary Fibrosis in Rat: Comparison with Dexamethasone.New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types
P2860
Q34548370-65EF075B-9C43-421E-9C27-37D258E2B66DQ35170946-E978D0DF-230C-44C6-9064-EA086BDCDDF9Q35290282-2330D4D5-3444-44C7-9FC3-6BA3DC919B11Q36232231-18D17B63-AA63-4577-893A-BD0E85A4136BQ36287686-FB04F12B-EF64-4FDF-B869-9914669FAAF0Q36512529-BED827A4-766D-4A7A-96B7-DE6340D92EE8Q37029400-F9356CEB-172F-4F27-9BC1-FECC14545AF4Q44081103-0C0D59A3-CC9F-4337-A5D0-1CA6A271A520Q46837475-710AB97B-F145-4BF3-ADD4-07301C3C4A5DQ53531723-D5AA00F1-1F0E-4C4B-AC71-9F11177954CBQ57176906-64DA984C-A1F0-4EB7-AA68-4FF8D5B3E89D
P2860
Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@ast
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@en
type
label
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@ast
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@en
prefLabel
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@ast
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@en
P2093
P2860
P356
P1476
Does pretreatment of bone marr ...... al for dilated cardiomyopathy?
@en
P2093
Jinhua Piao
Lianhua Jin
Sirui Yang
P2860
P356
10.12659/MSMBR.883737
P577
2013-01-14T00:00:00Z